DK95091D0 - Anvendelse af acetyl-d-carnitin ved terapeutisk behandling af glaucoma - Google Patents

Anvendelse af acetyl-d-carnitin ved terapeutisk behandling af glaucoma

Info

Publication number
DK95091D0
DK95091D0 DK91950A DK95091A DK95091D0 DK 95091 D0 DK95091 D0 DK 95091D0 DK 91950 A DK91950 A DK 91950A DK 95091 A DK95091 A DK 95091A DK 95091 D0 DK95091 D0 DK 95091D0
Authority
DK
Denmark
Prior art keywords
carnitin
glaucoma
acetyl
therapeutic treatment
therapeutic
Prior art date
Application number
DK91950A
Other languages
English (en)
Other versions
DK95091A (da
DK175891B1 (da
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of DK95091A publication Critical patent/DK95091A/da
Publication of DK95091D0 publication Critical patent/DK95091D0/da
Application granted granted Critical
Publication of DK175891B1 publication Critical patent/DK175891B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK199100950A 1988-12-01 1991-05-21 Anvendelse af acetyl-D-carnitin til fremstilling af et farmaceutisk præparat til terapeutisk behandling af glaukoma DK175891B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT8848614A IT1224795B (it) 1988-12-01 1988-12-01 Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
IT4861488 1988-12-01
IT8900076 1989-11-27
PCT/IT1989/000076 WO1990006111A1 (en) 1988-12-01 1989-11-27 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma

Publications (3)

Publication Number Publication Date
DK95091A DK95091A (da) 1991-05-21
DK95091D0 true DK95091D0 (da) 1991-05-21
DK175891B1 DK175891B1 (da) 2005-05-30

Family

ID=11267644

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100950A DK175891B1 (da) 1988-12-01 1991-05-21 Anvendelse af acetyl-D-carnitin til fremstilling af et farmaceutisk præparat til terapeutisk behandling af glaukoma

Country Status (13)

Country Link
US (2) US5145871A (da)
EP (1) EP0446268B1 (da)
JP (1) JP2763400B2 (da)
KR (1) KR950004885B1 (da)
AU (1) AU628116B2 (da)
CA (1) CA2004239C (da)
DK (1) DK175891B1 (da)
ES (1) ES2040106T3 (da)
GR (1) GR1000465B (da)
IE (1) IE62568B1 (da)
IT (1) IT1224795B (da)
WO (1) WO1990006111A1 (da)
ZA (1) ZA899176B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
PT951909E (pt) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
JP2003529561A (ja) * 2000-02-08 2003-10-07 ワックス、マーティン、ビー 緑内障の治療法
IL159050A0 (en) * 2001-07-06 2004-05-12 Ciba Sc Holding Ag Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3, 5-dihydroy heptanoic acid derivatives, and intermediates thereof
KR101072867B1 (ko) 2001-10-31 2011-10-17 유니버시티 오브 노스 텍사스 헬스 사이언스 센터 뼈 형태발생 단백질(ｂｍｐ), ｂｍｐ 수용체 및 ｂｍｐ 결합 단백질 및 녹내장 진단 및 치료에서 그의 용도
ITRM20020492A1 (it) * 2002-10-01 2004-04-02 Sigma Tau Ind Farmaceuti Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.
EP1594439A2 (en) 2003-02-13 2005-11-16 Albert Einstein College Of Medicine Of Yeshiva University REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US6951658B1 (en) 2003-07-08 2005-10-04 Pearson Research & Development Limited Emu-based compositions for mental well-being and method of use
US7718697B2 (en) * 2003-12-17 2010-05-18 Alcon, Inc. Method for treating glaucoma comprising administering α-lipoic acid
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EP2363126A1 (en) 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
US9114120B2 (en) 2010-11-22 2015-08-25 Sigma-Tau Industrie Farmaceutiche Riunite, S.P.A. Therapeutical method for the treatment of the Leber optic neuropathy
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
ES2896336T3 (es) 2011-12-07 2022-02-24 Allergan Inc Suministro eficiente de lípidos a película lagrimal humana usando un sistema de emulsión sensible a sales
EP2783695A1 (en) 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin
KR102487299B1 (ko) 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
IT202100020729A1 (it) 2021-08-02 2023-02-02 Univ Degli Studi Di Napoli Federico Ii Preparazione combinata per il trattamento della malattia di Pompe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262864A (en) * 1982-09-17 1989-11-14 Clarence D. Cone Method for producing oncolysis

Also Published As

Publication number Publication date
EP0446268A1 (en) 1991-09-18
JP2763400B2 (ja) 1998-06-11
IT1224795B (it) 1990-10-24
GR890100797A (en) 1991-03-15
WO1990006111A1 (en) 1990-06-14
CA2004239A1 (en) 1990-06-01
IE62568B1 (en) 1995-02-08
GR1000465B (el) 1992-07-30
CA2004239C (en) 1999-11-09
DK95091A (da) 1991-05-21
US5432199A (en) 1995-07-11
IT8848614A0 (it) 1988-12-01
EP0446268B1 (en) 1993-04-14
AU628116B2 (en) 1992-09-10
DK175891B1 (da) 2005-05-30
IE893840L (en) 1990-06-01
ZA899176B (en) 1990-09-26
ES2040106T3 (es) 1993-10-01
KR950004885B1 (ko) 1995-05-15
JPH04502161A (ja) 1992-04-16
US5145871A (en) 1992-09-08
KR920702216A (ko) 1992-09-03
AU4658489A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
DK95091A (da) Anvendelse af acetyl-d-carnitin ved terapeutisk behandling af glaucoma
MX18467A (es) Agentes terapeuticos de quinuclidinas
DK177690D0 (da) Behandling af fedme
DK304190A (da) Terapeutisk praeparat indeholdende blokeringsmidler til behandling af chocktilstande
DK0434278T3 (da) Behandling af fugle
KR900701323A (ko) 신규한 녹내장 치료용 안과 제제
DK254887D0 (da) Salve til behandling af hudsygdomme
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO914997D0 (no) Fremgangsmaate ved behandling av sandstensformasjoner
DK31386D0 (da) Behandling af proliferative hudsygdomme
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
NO942756D0 (no) Behandling av glaucoma
IT1239064B (it) Uso terapeutico del dipiridamolo
NO920983D0 (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
NO172115C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bronkospasmolytiske forbindelser
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
IT1222182B (it) Macchina per il trattamento terapeutico di lombalgie e lombosciatalgie
DK236489A (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser
KR890701106A (ko) 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도
DK401589D0 (da) Fremgangsmaade ved behandling af slagtekroppe ellerdele deraf
NO920694D0 (no) Fremgangsmaate for etterbehandling av tremasse
IT9022309A0 (it) Composizione terapeutica per il trattamento della vitiligine
DK305289A (da) Apparat til behandling af reumatiske sygdomme
NO921408L (no) Fremgangsmaate ved behandling av huder

Legal Events

Date Code Title Description
PUP Patent expired